Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Wednesday, May 1, 2013 - 09:23, By: Amy Madsen
Name: Tirasemtiv (CK-2017357)
How it works: Tirasemtiv, developed by Cytokinetics, is designed to increase the sensitivity of muscle fibers to calcium, resulting in a potential increase in muscle force generation.
CK-2017357 is being tested in combination with riluzole; Neuralstem is testing its stem cells in the cervical region of the spinal cord
Posted on Thursday, November 10, 2011 - 15:43, By: Amy Madsen
Editor's note 3/19/12: This story has been updated to reflect that Neuralstem has begun testing its stem cells in the cervical (neck) region of the spinal cord.
Two human clinical trials to test therapies in amyotrophic lateral sclerosis (ALS) are moving forward.
An ALS Therapy Development Institute Webcast summarizes research progress as of July 2009
Posted on Wednesday, July 29, 2009 - 10:38, By: Amy Madsen
On July 16, 2009, the MDA-supported ALS Therapy Development Institute (ALS TDI) gave its quarterly research update in a Webcast that's now archived on the Institute's site and accessible to all who register. (See Research Update Q209.)